CUVIS-JOINT Trademark
Serial Number: 79358786 • Registration: 7301572
CUVIS-JOINT is a trademark filed by
CUREXO Inc.
on November 7, 2022. The trademark is classified under Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jihun Kim Bridgeway IP Law Group, PLLC
11350 Random Hills Rd
Suite 800
Fairfax
VA 22030
Trademark Details
Filing Date
November 7, 2022
Registration Date
February 13, 2024
Published for Opposition
November 28, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 3, 2024 FINV
FINAL DISPOSITION NOTICE SENT TO IB
May 16, 2024 FICS
FINAL DISPOSITION PROCESSED
May 16, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 8, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 8, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2023 CNSA
ASSIGNED TO EXAMINER
Oct 19, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 10, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 19, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 19, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 31, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 30, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 30, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 29, 2022 REPR
